Biodesix, Inc. VeriStrat Study Highlighted in Prominent Series of Oncology Meetings

Published: Aug 06, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced that the Phase III clinical trial data for its VeriStrat® test will be a featured abstract in the 2013 Best of ASCO meetings. Topics for the meeting are determined by a panel of medical oncology experts who select abstracts that demonstrate practice-changing science, from the 2013 Annual Meeting of the American Society of Clinical Oncology®. The series visits Chicago, Los Angeles and Boston throughout the month of August.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news